CK15

N/A

Report date: 2025/05/30 16:59:32
NME

Base Information

Drug NameCK15
Drug Alias NameCK-15Vida-5VS-105
ClassificationSmall molecules
Mechanisms of ActionVitamin D receptor modulators
TargetsVitamin D receptor
Therapy Area/IndicationsHyperparathyroidism, SecondaryHyperparathyroidismRenal Insufficiency, Chronic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesVidasym Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesXinkai Medicine And Chemical Intermediates (Shanghai) Co LtdXinkai Medicine Technology (Shanghai) Co Ltd
Inactive CompaniesVidasym Inc
Active IndicationsHyperparathyroidism, SecondaryHyperparathyroidismRenal Insufficiency, Chronic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A